• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从患者角度看12年间结直肠癌和前列腺癌的早期检测工作:KABOT调查研究结果

Early detection efforts for colorectal and prostate cancer from the patient's perspective over the course of 12 years: results of the KABOT survey study.

作者信息

Braun Kay-Patrick, Maurer Julia, Wolff Ingmar, Vogel Torsten, Lebentrau Steffen, May Matthias, Herrmann Markus

机构信息

Institute of General Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

MVZ Dr. Braun GmbH, Cottbus, Germany.

出版信息

Prim Health Care Res Dev. 2024 Dec 16;25:e68. doi: 10.1017/S1463423624000653.

DOI:10.1017/S1463423624000653
PMID:39676729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11669801/
Abstract

AIM

This study investigates the level of knowledge and utilization of colorectal cancer (CRC) and prostate cancer (PCa) early detection measures (EDMs) over a period of 12 years in general practice from the patient's perspective.

BACKGROUND

The role of general practitioners (GPs) in EDMs for CRC and PCa in Germany is not well-documented with comprehensive data.

METHODS

We conducted a patient-centric survey in the German federal state of Berlin-Brandenburg at a 12-year interval to examine the role of GPs in EDMs for CRC and PCa. In 2009, 55 GPs were tasked with informing 50 consecutive male patients, each aged over 35, about participating in a survey study (study phase 1/SP1). To evaluate changes over 12 years, a new survey involving 50 male patients from each of 150 GPs was conducted from October 2021 to March 2022 (SP2).

FINDINGS

We thoroughly reviewed the questionnaires of 890 patients, with 755 in SP1 and 135 in SP2. Patients showed greater awareness of recommendations regarding colonoscopy compared to prostate-specific antigen (PSA) testing. GPs were the most frequently reported source of information for both EDMs in our cohort. Comparing the two study phases, no significant difference in specific awareness of colonoscopy or PSA testing was found among men eligible for EDMs. However, there was a notable increase in the role of health insurance companies as a source of information about colonoscopy over time. Nearly 60% of included patients underwent colonoscopy and/or PSA testing as EDMs.

CONCLUSION

The number of EDMs performed among study participants did not increase over time. Our study confirms that GPs remain the primary source of information about EDMs among the study participants.

摘要

目的

本研究从患者角度调查了12年间全科医疗中结直肠癌(CRC)和前列腺癌(PCa)早期检测措施(EDMs)的知识水平和使用情况。

背景

德国全科医生(GPs)在CRC和PCa的EDMs中的作用尚无全面数据的充分记录。

方法

我们在德国联邦州柏林-勃兰登堡每隔12年进行一次以患者为中心的调查,以研究GPs在CRC和PCa的EDMs中的作用。2009年,55名全科医生负责告知连续50名年龄超过35岁的男性患者参与一项调查研究(研究阶段1/SP1)。为评估12年间的变化,2021年10月至2022年3月进行了一项新调查,涉及150名全科医生中每位医生的50名男性患者(SP2)。

结果

我们全面审查了890名患者的问卷,其中SP1有755名,SP2有135名。与前列腺特异性抗原(PSA)检测相比,患者对结肠镜检查建议的知晓度更高。在我们的队列中,全科医生是这两种EDMs最常被报告的信息来源。比较两个研究阶段,符合EDMs条件的男性在结肠镜检查或PSA检测的具体知晓度上没有显著差异。然而,随着时间推移,健康保险公司作为结肠镜检查信息来源的作用显著增加。近60%的纳入患者接受了结肠镜检查和/或PSA检测作为EDMs。

结论

研究参与者中进行的EDMs数量未随时间增加。我们的研究证实,全科医生仍然是研究参与者中EDMs信息的主要来源。

相似文献

1
Early detection efforts for colorectal and prostate cancer from the patient's perspective over the course of 12 years: results of the KABOT survey study.从患者角度看12年间结直肠癌和前列腺癌的早期检测工作:KABOT调查研究结果
Prim Health Care Res Dev. 2024 Dec 16;25:e68. doi: 10.1017/S1463423624000653.
2
Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.评估前列腺特异性抗原作为非泌尿外科医生早期检测前列腺癌工具的应用:全科医生和内科专家代表性横断面问卷调查研究结果
Urol Int. 2014;93(2):160-9. doi: 10.1159/000356367. Epub 2014 Mar 5.
3
Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.目标人群对捷克共和国结直肠癌筛查障碍和促进因素的观点。
World J Gastroenterol. 2019 Mar 7;25(9):1132-1141. doi: 10.3748/wjg.v25.i9.1132.
4
[Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].[使用前列腺特异性抗原进行前列腺癌筛查:普通医生和检验医生的观点]
Semergen. 2018 Sep;44(6):409-419. doi: 10.1016/j.semerg.2018.02.001. Epub 2018 Mar 21.
5
[Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].[用于前列腺癌早期检测的前列腺特异性抗原检测率:德国结果与当前国际数据的首次比较]
Urologe A. 2014 May;53(5):715-24. doi: 10.1007/s00120-014-3453-0.
6
GPs views and understanding of PSA testing, screening and early detection; survey.全科医生对前列腺特异性抗原(PSA)检测、筛查及早期检测的看法和理解;调查
Int J Clin Pract. 2016 May;70(5):389-95. doi: 10.1111/ijcp.12794.
7
Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?在美国对男性进行前列腺癌和结直肠癌筛查:实际做法是否符合证据?
JAMA. 2003 Mar 19;289(11):1414-20. doi: 10.1001/jama.289.11.1414.
8
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.前列腺癌的前列腺特异性抗原检测:对英国全科医生观点及报告实践的在线调查
BMC Fam Pract. 2005 Jun 9;6(1):24. doi: 10.1186/1471-2296-6-24.
9
Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey.德国泌尿科医生和全科医生对前列腺特异性抗原检测的态度及使用情况:一项调查
Front Oncol. 2021 Jun 4;11:691197. doi: 10.3389/fonc.2021.691197. eCollection 2021.
10
Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.对结直肠癌高危患者粪便免疫化学检测的态度:英格兰全科医生的在线调查。
Br J Gen Pract. 2018 Nov;68(676):e757-e764. doi: 10.3399/bjgp18X699413. Epub 2018 Oct 8.

本文引用的文献

1
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).西班牙语男性前列腺癌筛查知识和实践:个人和临床特征的重要性(PROSHADE 研究)。
PLoS One. 2024 May 30;19(5):e0303203. doi: 10.1371/journal.pone.0303203. eCollection 2024.
2
Enhancing colorectal cancer prevention: a national assessment of public awareness in Egypt.提高结直肠癌预防意识:埃及全国公众认知度评估
BMC Public Health. 2024 May 27;24(1):1415. doi: 10.1186/s12889-024-18746-w.
3
IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance.参与式前列腺癌男性研究(IMPROVER):评估患者在检测、诊断和监测方面的体验。
Clin Genitourin Cancer. 2024 Jun;22(3):102063. doi: 10.1016/j.clgc.2024.102063. Epub 2024 Mar 4.
4
Urologists' and general practitioners' knowledge, beliefs and practice relevant for opportunistic prostate cancer screening: a PRISMA-compliant systematic review.泌尿外科医生和全科医生在机会性前列腺癌筛查方面的知识、信念及实践:一项遵循PRISMA标准的系统评价
Front Med (Lausanne). 2024 Feb 16;11:1283654. doi: 10.3389/fmed.2024.1283654. eCollection 2024.
5
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.比较数字直肠检查和前列腺特异性抗原作为前列腺癌筛查试验的性能:系统评价和荟萃分析。
Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4.
6
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.基于前列腺特异性抗原的筛查对前列腺癌发病率和死亡率影响的详细评估:前列腺癌筛查的欧洲随机研究 Rotterdam 部分 21 年随访结果。
Eur Urol. 2023 Oct;84(4):426-434. doi: 10.1016/j.eururo.2023.03.016. Epub 2023 Apr 5.
7
Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment.与癌症筛查知识和参与社区健康评估相关的可改变的患者报告因素。
Am J Surg. 2023 Apr;225(4):617-629. doi: 10.1016/j.amjsurg.2022.10.059. Epub 2022 Nov 2.
8
A novel blood based triage test for colorectal cancer in primary care: a pilot study.基层医疗中一种用于结直肠癌的新型血液分诊检测:一项试点研究。
BJGP Open. 2023 Mar 21;7(1). doi: 10.3399/BJGPO.2022.0077. Print 2023 Mar.
9
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.结肠镜筛查对结直肠癌发病风险和相关死亡的影响。
N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.
10
Primary Care Practitioner Perceptions on the Follow-up of Abnormal Cancer Screening Test Results.初级保健医生对异常癌症筛查检测结果的随访看法。
JAMA Netw Open. 2022 Sep 1;5(9):e2234194. doi: 10.1001/jamanetworkopen.2022.34194.